Wed, Oct 06, 2021
The board has set us a target to more than double our revenue and profit from the FY'20 levels by FY'23, both through organic as well as inorganic routes.
More >
Sat, Jul 31, 2021
Earnings before interest, taxes, depreciation and amortisation (EBITDA) moved up 56 per cent to Rs 37 crore in Q1 FY22 from Rs 24 crore in Q1 FY21
Tue, Jul 13, 2021
"Unitop, which we acquired, is an agrochemical focused speciality chemicals segment that we were not doing. So, this will add to our segment at which we were working, the 100% acquisition will be completed over the next three years. We are expecting that our next year’s EBITDA will be double of the last year," Sunil Chari, Promoter & Managing Director, Rossari Biotech says
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
